Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose
AbstractNeurotensin (NTS)-polyplex is a nanoparticle system for targeted gene delivery that holds great promise for treatment of Parkinson’s disease and various types of cancer. However, the high instability in aqueous suspension of NTS-polyplex nanoparticles is a major limitation for their widespread clinical use. To overcome this obstacle, we developed a clinical formulation and a lyophilization process for NTS-polyplex nanoparticles. The reconstituted samples were compared with fresh preparations by using transmission electron microscopy, dynamic light scattering, electrophoretic mobility, circular dichroism and transfection assays in vitro and in vivo. Our formulation was able to confer lyoprotection and stability to these nanoparticles. In addition, transmission electron microscopy (TEM) and size exclusion-high performance liquid chromatography (SEC-HPLC) using a radioactive tag revealed that the interaction of reconstituted nanoparticles with fetal bovine or human serum did not alter their biophysical features. Furthermore, the formulation and the lyophilization procedure guaranteed functional NTS-polyplex nanoparticles for at least six months of storage at 25 °C and 60% relative humidity. Our results offer a pharmaceutical guide for formulation and long-term storage of NTS-polyplex nanoparticles that could be applied to other polyplexes. View Full-Text
- Supplementary File 1:
Supplementary (PDF, 1251 KB)
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Aranda-Barradas, M.E.; Márquez, M.; Quintanar, L.; Santoyo-Salazar, J.; Espadas-Álvarez, A.J.; Martínez-Fong, D.; García-García, E. Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose. Pharmaceutics 2018, 10, 5.
Aranda-Barradas ME, Márquez M, Quintanar L, Santoyo-Salazar J, Espadas-Álvarez AJ, Martínez-Fong D, García-García E. Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose. Pharmaceutics. 2018; 10(1):5.Chicago/Turabian Style
Aranda-Barradas, María E.; Márquez, Maripaz; Quintanar, Liliana; Santoyo-Salazar, Jaime; Espadas-Álvarez, Armando J.; Martínez-Fong, Daniel; García-García, Elizabeth. 2018. "Development of a Parenteral Formulation of NTS-Polyplex Nanoparticles for Clinical Purpose." Pharmaceutics 10, no. 1: 5.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.